Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus dexmedetomidine for opiate withdrawal syndrome in ICU patients
IRCT20220305054196N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in opioid withdrawal comparing Dexmedetomidine arm with Clonidine arm (2 arms). Primary endpoint: Symptoms of opium withdrawal syndrome. Started May 2023; status: completed.
02
Drugs
clonidinedexmedetomidine
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on IRCT20220305054196N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220305054196N3.